Effect of Transcranial Alternative Current Stimulation at Alpha Frequency (α-tACS) on Stressed Healthy Subjects
CAF-TAS
Biological, Neuropsychological and Electrophysiological Effect of Transcranial Alternative Current Stimulation at Alpha Frequency (α-tACS) on Stressed Healthy Subjects
1 other identifier
interventional
40
1 country
1
Brief Summary
stress. Notably, several studies reported that stress could alter impulsivity, source monitoring, and time perception. Several mechanisms are involved in the response to a stress factor, among them the hypothalamic-pituitary-adrenal (HPA) axis. The cortisol reactivity (it means the cortisol secretion after the exposure to a standardized stress factor) is a reliable tool to assess the function of HPA. Cortisol secretion is bidirectionally influenced by the prefrontal cortex (PFC), which is involved in the expression and regulation of stress as well. The asymmetry of the alpha band (AFα) is a well known electrophysiological parameter to assess the function of PFC. More precisely, AFα is arising a growing interest, as it is believed to be correlated with the cortisol reactivity. Modifying this asymmetry could influence the stress response. Transcranial Alternating Current Stimulation (tACS) consists in delivering a sinusoidal alternating current between two electrodes placed on the scalp at a predefined frequency. Previous studious reported that tACS, if delivered at the alpha frequency, increased the alpha band in the stimulated areas
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Jan 2024
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2023
CompletedStudy Start
First participant enrolled
January 24, 2024
CompletedFirst Posted
Study publicly available on registry
January 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
March 7, 2024
December 1, 2023
3 years
December 20, 2023
March 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Area under the curve (AUC) of the cortisol secretion after the stress task.
Samples of salivary cortisol will be repeatedly (10 occurences) collected during the experiment. The collection will take place before, during and after the stress task.
1 day
Secondary Outcomes (13)
Effect of α-tACS on the cortisol awakening response in stressed healthy subjects
4 days
Effect of α-tACS on the molecular reactivity to stress
1 day
Effect of α-tACS on the molecular reactivity to stress
1 day
Effect of α-tACS on the molecular reactivity to stress
1 day
Effect of α-tACS on the molecular reactivity to stress
1 day
- +8 more secondary outcomes
Study Arms (2)
Active tACS stimulation
EXPERIMENTALTranscranial alternative current stimulation (tACS) at alpha frequency Single session of tACS : 30 minutes, 2mA, frequency = 10Hz, both electrodes located on the dorsolateral prefrontal cortex (left and right)
Sham stimulation
PLACEBO COMPARATORSingle session of tACS sham stimulation : both electrodes located on the dorsolateral prefrontal cortex (left and right) ; real current delivered for the first and last 30s of the total stimulation time (ramp-in and ramp-out)
Interventions
Single session of tACS
Eligibility Criteria
You may qualify if:
- Right-handed Men and Women aged between 18 and 45
- If woman, hormonal contraception required
- Having given their written informed consent
- Affiliated with a social security scheme
- French speakers and readers
You may not qualify if:
- Contraindication to the exposure to exposure to tACS
- Current psychiatric disorder as classified in the DSM-5
- Regular intake of any psychotropic drug or Beta Blocker
- Recent exposure to a traumatic event
- Any debilitating condition making the experimental procedure not feasible
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Le Vinatier
Bron, AURA, 69678 CEDEX, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants and experimenters (including α-tACS operator) will not be informed about the nature (active or placebo) of the stimulation they will receive
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2023
First Posted
January 29, 2024
Study Start
January 24, 2024
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2028
Last Updated
March 7, 2024
Record last verified: 2023-12